ALFA Filings
Every announcement, straight from the exchange
Every Solara Active Pharma Sciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Solara Active Pharma Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details equity ownership across various investor categories.
Solara Active Pharma received an ESG rating of 63 ('Strong' category) from Crisil ESG Ratings for the fiscal year 2026, an upgrade from the prior year.
Solara Active Pharma Sciences is notifying physical shareholders to update their PAN, KYC, and nomination details per SEBI circulars. This is a routine regulatory compliance intimation.
Solara Active Pharma Sciences Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This is a periodic regulatory compliance disclosure.
The company filed its quarterly shareholding pattern under Regulation 31. This routine regulatory disclosure details shareholding distribution across various investor categories.
Solara Active Pharma submitted its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed zero material non-compliances, ensuring robust governance standards.